Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.93 +0.03 (+3.33%)
At close: Oct 2, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Return on Invested Capital [ROIC] (2014 - 2019)

Updated

Lineage Cell Therapeutics' Return on Invested Capital [ROIC] was -33.06% in Q1 2019.

Analysis

Lineage Cell Therapeutics (LCTX) Return on Invested Capital [ROIC] (2014 - 2019) Analysis & Trends

For FY2018, Return on Invested Capital [ROIC] at Lineage Cell Therapeutics came in at -32.56%.

  • The Q1 2019 figure marks the highest quarterly Return on Invested Capital [ROIC] since Q3 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 16.10%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 18.68%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 3.56%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 21.95%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 28.83%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 14.33%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 13.44%
10 Lineage Cell Therapeutics 235.20 Mn 33.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 -33.06%
Sep 30, 2017 -20.82%
Sep 30, 2014 -141.18%
API Access

Lineage Cell Therapeutics Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=LCTX&period=max&api_key=YOUR_API_KEY